TABLE 2.
Target organ | Estimated radiation dose (mSv/MBq) | ||
---|---|---|---|
Average | SD | Percentage coefficient of variation | |
Adrenals | 1.46E−02 | 5.18E−04 | 3.55E+00 |
Brain | 9.86E−03 | 5.46E−04 | 5.54E+00 |
Breasts | 9.96E−03 | 4.26E−04 | 4.28E+00 |
Gallbladder wall | 1.49E−02 | 6.77E−04 | 4.54E+00 |
Lower large intestine wall | 1.29E−02 | 8.43E−04 | 6.52E+00 |
Small intestine | 1.38E−02 | 2.60E−03 | 1.88E+01 |
Stomach wall | 1.38E−02 | 6.47E−04 | 4.68E+00 |
Upper large intestine wall | 1.29E−02 | 4.23E−04 | 3.29E+00 |
Heart wall | 1.23E−02 | 3.93E−04 | 3.21E+00 |
Kidneys | 9.21E−02 | 2.84E−02 | 3.08E+01 |
Liver | 4.50E−02 | 1.52E−02 | 3.38E+01 |
Lungs | 1.15E−02 | 3.52E−04 | 3.06E+00 |
Muscle | 1.13E−02 | 4.47E−04 | 3.96E+00 |
Ovaries | 1.31E−02 | 8.32E−04 | 6.35E+00 |
Pancreas | 1.67E−02 | 1.37E−03 | 8.20E+00 |
Pituitary gland | 4.16E−02 | 3.20E−02 | 7.70E+01 |
Hematopoietic cells | 9.61E−03 | 3.47E−04 | 3.61E+00 |
Bone-forming cells | 1.55E−02 | 7.39E−04 | 4.76E+00 |
Salivary glands | 1.17E−02 | 7.82E−03 | 6.68E+01 |
Skin | 9.66E−03 | 4.24E−04 | 4.39E+00 |
Spleen | 2.82E−01 | 1.21E−01 | 4.28E+01 |
Testes | 1.12E−02 | 6.78E−04 | 6.06E+00 |
Thymus | 1.09E−02 | 4.93E−04 | 4.51E+00 |
Thyroid | 1.87E−02 | 1.05E−02 | 5.65E+01 |
Urinary bladder wall | 1.25E−01 | 6.18E−02 | 4.96E+01 |
Uterus (estimated)* | 1.47E−02 | 1.56E−03 | 1.06E+01 |
Total body | 1.34E−02 | 2.83E−04 | 2.11E+00 |
ED | 2.57E−02 | 2.85E−03 | 1.11E+01 |
Uterus dosimetry is estimated because all subjects were men.